Trials / Terminated
TerminatedNCT04919356
Parkinson's Disease G2019S LRRK2 Genetic Testing Program
G2019S LRRK2 Parkinson's Disease: Increasing Awareness and Genetic Testing Program
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 836 (actual)
- Sponsor
- Escape Bio, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Increase awareness of the G2019S LRRK2 mutation in Parkinson's and no cost genetic testing program.
Detailed description
This program is intended to increase awareness of genetic Parkinson's, in particular the G2019S LRRK2 mutation, and provide no cost genetic testing to determine if they carry the G2019S LRRK2 mutation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | G2019S LRRK2 | No cost genetic testing for G2019S LRRK2 |
Timeline
- Start date
- 2021-06-08
- Primary completion
- 2022-12-05
- Completion
- 2022-12-05
- First posted
- 2021-06-09
- Last updated
- 2023-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04919356. Inclusion in this directory is not an endorsement.